Paladin Advisory Group, LLC Abb Vie Inc. Transaction History

Paladin Advisory Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	BUY	$133.59 - $154.65 $133 - $154	1 Added 0.77%	131 $19,000
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $132 - $164	1 Added 0.78%	130 $17,000
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $18,654 - $21,483	129 New	129 $20,000
Q1 2022 Apr 15, 2022	BUY	$131.98 - $163.75 $16,233 - $20,141	123 New	123 $20,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Paladin Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Paladin Advisory Group, LLC with notifications on news.